Sandbox: ATL: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Replaced content with "high lactate dehydrogenase (LDH) high leukemic counts hypercalcemia poor clinical performance status")
Line 1: Line 1:
* Common risk factors in the development of adult T-cell leukemia among [[HTLV]] carriers include:<ref name="pmid22973265">{{cite journal| author=Iwanaga M, Watanabe T, Yamaguchi K| title=Adult T-cell leukemia: a review of epidemiological evidence. | journal=Front Microbiol | year= 2012 | volume= 3 | issue=  | pages= 322 | pmid=22973265 | doi=10.3389/fmicb.2012.00322 | pmc=PMC3437524 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22973265  }} </ref>
high lactate dehydrogenase (LDH)  
:* Vertical transmission of HTLV [[infection]] during [[infancy]]
high leukemic counts
:* Male sex
hypercalcemia
:* Specific [[human leukocyte antigen]]s such as:
poor clinical performance status
::* [[HLA-A]] 26
::* [[HLA-B]] 4002
::* HLA-B 4801
:* Patients with a [[Strongyloides stercoralis]] co-infection
:* An elevated soluble [[interleukin-2 receptor]] levels (> 500 U/ml)
:* An elevated  anti-HTLV-1 [[antibody]] [[titer]]
:* An elevated HTLV proviral load level (> 4 copies per 100 peripheral blood [[mononuclear cell]]s)
:* An elevated [[WBC count]] (> 9,000/μL)
:* An elevated abnormal [[lymphocyte]] count
:* A decreased level of anti-Tax reactivity

Revision as of 18:13, 24 January 2016

high lactate dehydrogenase (LDH) high leukemic counts hypercalcemia poor clinical performance status